Page last updated: 2024-09-05

lasofoxifene and Bone Loss, Osteoclastic

lasofoxifene has been researched along with Bone Loss, Osteoclastic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hamilton, CJ; Jamal, SA; Swan, VJ1
Armamento-Villareal, R; Brodt, MD; Caruso, PL; Civelli, M; Civitelli, R; Galbiati, E; Halstead, LR; Mueller, C; Napoli, N; Nawaz, A; Sheikh, S; Silva, MJ1
Chidsey-Frink, KL; Crawford, DT; Ke, HZ; Qi, H; Thompson, DD1

Reviews

1 review(s) available for lasofoxifene and Bone Loss, Osteoclastic

ArticleYear
Lasofoxifene in osteoporosis and its place in therapy.
    Advances in therapy, 2010, Volume: 27, Issue:12

    Topics: Bone Density; Bone Resorption; Breast Neoplasms; Cardiovascular Diseases; Clinical Trials, Phase III as Topic; Drug Approval; Europe; Female; Humans; Middle Aged; Musculoskeletal Diseases; Osteoporosis, Postmenopausal; Pyrrolidines; Selective Estrogen Receptor Modulators; Tetrahydronaphthalenes; Women's Health

2010

Other Studies

2 other study(ies) available for lasofoxifene and Bone Loss, Osteoclastic

ArticleYear
A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2005, Volume: 20, Issue:12

    Topics: Absorptiometry, Photon; Amino Acids; Animals; Benzopyrans; Biomechanical Phenomena; Blood; Body Composition; Body Weight; Bone and Bones; Bone Density; Bone Resorption; Cholesterol; Compressive Strength; Estrogen Receptor Modulators; Ethinyl Estradiol; Female; Femur; Femur Neck; Lumbar Vertebrae; Organ Size; Osteoclasts; Osteogenesis; Ovariectomy; Piperidines; Pyrrolidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Tetrahydronaphthalenes; Tibia; Tomography, X-Ray Computed; Triglycerides; Uterus; Weight-Bearing

2005
Lasofoxifene (CP-336,156) protects against the age-related changes in bone mass, bone strength, and total serum cholesterol in intact aged male rats.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2001, Volume: 16, Issue:4

    Topics: Adipose Tissue; Aging; Animals; Body Composition; Bone and Bones; Bone Density; Bone Resorption; Cholesterol; Drug Evaluation, Preclinical; Elasticity; Femur; Hypercholesterolemia; Lumbar Vertebrae; Male; Organ Size; Osteocalcin; Osteoclasts; Osteoporosis; Prostate; Pyrrolidines; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Stress, Mechanical; Tetrahydronaphthalenes; Tibia; Tomography, X-Ray Computed

2001